Umar Mehraj

1.6k total citations
24 papers, 714 citations indexed

About

Umar Mehraj is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Umar Mehraj has authored 24 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Umar Mehraj's work include Advanced Breast Cancer Therapies (8 papers), Cancer-related Molecular Pathways (6 papers) and Immune cells in cancer (4 papers). Umar Mehraj is often cited by papers focused on Advanced Breast Cancer Therapies (8 papers), Cancer-related Molecular Pathways (6 papers) and Immune cells in cancer (4 papers). Umar Mehraj collaborates with scholars based in India, Saudi Arabia and United States. Umar Mehraj's co-authors include Manzoor Ahmad Mir, Nissar Ahmad Wani, Hina Qayoom, Shazia Sofi, Bashir Ahmad Sheikh, Shariqa Aisha, Abdullah Almilaibary, Mustfa Alkhanani, Abid Hamid and Basharat Ahmad Bhat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Seminars in Cancer Biology.

In The Last Decade

Umar Mehraj

24 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Umar Mehraj India 16 366 300 165 154 143 24 714
Linghuan Zhang China 4 469 1.3× 334 1.1× 140 0.8× 256 1.7× 67 0.5× 8 996
Elahe Safari Iran 10 419 1.1× 284 0.9× 139 0.8× 233 1.5× 163 1.1× 35 887
Milica Nedeljković Serbia 7 418 1.1× 307 1.0× 111 0.7× 228 1.5× 89 0.6× 13 747
Bozhi Shi China 4 443 1.2× 267 0.9× 98 0.6× 277 1.8× 51 0.4× 7 764
Preethi Ravindranathan United States 14 560 1.5× 263 0.9× 241 1.5× 256 1.7× 49 0.3× 18 1.0k
Itishree Kaushik United States 10 435 1.2× 212 0.7× 90 0.5× 156 1.0× 121 0.8× 12 756
Muntasir Mamun Majumder Finland 17 597 1.6× 205 0.7× 57 0.3× 121 0.8× 64 0.4× 33 985
Ting Xiao China 16 354 1.0× 102 0.3× 116 0.7× 179 1.2× 101 0.7× 29 689
Helena Cirenajwis Sweden 13 371 1.0× 308 1.0× 82 0.5× 154 1.0× 67 0.5× 14 649
Shilpa Kuttikrishnan Qatar 21 781 2.1× 257 0.9× 85 0.5× 240 1.6× 111 0.8× 46 1.2k

Countries citing papers authored by Umar Mehraj

Since Specialization
Citations

This map shows the geographic impact of Umar Mehraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umar Mehraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umar Mehraj more than expected).

Fields of papers citing papers by Umar Mehraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umar Mehraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umar Mehraj. The network helps show where Umar Mehraj may publish in the future.

Co-authorship network of co-authors of Umar Mehraj

This figure shows the co-authorship network connecting the top 25 collaborators of Umar Mehraj. A scholar is included among the top collaborators of Umar Mehraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umar Mehraj. Umar Mehraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehraj, Umar, et al.. (2024). Chloroquine sensitises hypoxic colorectal cancer cells to ROS-mediated cell death via structural disruption of pyruvate dehydrogenase kinase 1. Free Radical Biology and Medicine. 227. 656–666. 1 indexed citations
2.
Lone, Mohammad Nadeem, et al.. (2023). Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase Inhibitors. Applied Biochemistry and Biotechnology. 195(10). 6212–6231. 4 indexed citations
3.
Sofi, Shazia, Umar Mehraj, Nusrat Jan, et al.. (2023). Clinicopathological Significance and Expression Pattern of Bcl2 in Breast Cancer: A Comprehensive in silico and in vitro Study. Saudi Journal of Biological Sciences. 31(2). 103916–103916. 9 indexed citations
4.
Sofi, Shazia, Umar Mehraj, Hina Qayoom, et al.. (2022). Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors. Medical Oncology. 39(9). 133–133. 59 indexed citations
5.
Mehraj, Umar, Umar Mushtaq, Manzoor Ahmad Mir, et al.. (2022). Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications. Seminars in Cancer Biology. 86(Pt 2). 769–783. 42 indexed citations
6.
Mehraj, Umar, Bader Alshehri, Azmat Ali Khan, et al.. (2022). Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis. Clinical Breast Cancer. 22(6). 567–578. 17 indexed citations
7.
Mehraj, Umar, et al.. (2022). Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction. Frontiers in Oncology. 12. 938052–938052. 24 indexed citations
8.
Qayoom, Hina, Umar Mehraj, Shazia Sofi, et al.. (2022). Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study. Medical Oncology. 39(10). 158–158. 10 indexed citations
9.
Mehraj, Umar, Nissar Ahmad Wani, Abid Hamid, et al.. (2022). Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941. Frontiers in Pharmacology. 13. 958443–958443. 20 indexed citations
10.
Mehraj, Umar, et al.. (2022). Cryptolepine Targets TOP2A and Inhibits Tumor Cell Proliferation in Breast Cancer Cells -An In vitroandIn silicoStudy. Anti-Cancer Agents in Medicinal Chemistry. 22(17). 3025–3037. 17 indexed citations
11.
Sofi, Shazia, Umar Mehraj, Hina Qayoom, et al.. (2022). Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications. Medical Oncology. 39(6). 106–106. 42 indexed citations
12.
Mehraj, Umar, Shazia Sofi, Bader Alshehri, & Manzoor Ahmad Mir. (2022). Expression pattern and prognostic significance of CDKs in breast cancer: An integrated bioinformatic study. Cancer Biomarkers. 34(3). 505–519. 11 indexed citations
13.
Mehraj, Umar, Muzafar A. Macha, Abid Hamid, et al.. (2021). The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities. Cellular Oncology. 44(6). 1209–1229. 69 indexed citations
14.
Mehraj, Umar, et al.. (2021). Tumor microenvironment promotes breast cancer chemoresistance. Cancer Chemotherapy and Pharmacology. 87(2). 147–158. 161 indexed citations
15.
Mehraj, Umar, Hina Qayoom, & Manzoor Ahmad Mir. (2021). Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives. Breast Cancer. 28(3). 539–555. 35 indexed citations
16.
Sheikh, Bashir Ahmad, et al.. (2020). Development of New Therapeutics to Meet the Current Challenge of Drug Resistant Tuberculosis. Current Pharmaceutical Biotechnology. 22(4). 480–500. 19 indexed citations
17.
Mir, Manzoor Ahmad, et al.. (2019). Recent Advances in Metabolites from Medicinal Plants in Cancer Prevention and Treatment. Current Immunology Reviews. 15(2). 185–201. 19 indexed citations
18.
Mir, Manzoor Ahmad & Umar Mehraj. (2019). Double-crosser of the Immune System: Macrophages in Tumor Progression and Metastasis. Current Immunology Reviews. 15(2). 172–184. 19 indexed citations
19.
Mir, Manzoor Ahmad, et al.. (2019). Nanobodies: The “Magic Bullets” in therapeutics, drug delivery and diagnostics. Human Antibodies. 28(1). 29–51. 48 indexed citations
20.
Mir, Manzoor Ahmad, et al.. (2018). Study on the quality control analysis of antiepileptic drugs using high-performance liquid chromatography. International Journal of Pharmaceutical Investigation. 8(3). 115–115. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linghuan Zhang Breakdown of academic impact, for papers by Elahe Safari Breakdown of academic impact, for papers by Milica Nedeljković Breakdown of academic impact, for papers by Bozhi Shi Breakdown of academic impact, for papers by Preethi Ravindranathan Breakdown of academic impact, for papers by Itishree Kaushik Breakdown of academic impact, for papers by Muntasir Mamun Majumder Breakdown of academic impact, for papers by Ting Xiao Breakdown of academic impact, for papers by Helena Cirenajwis Breakdown of academic impact, for papers by Shilpa Kuttikrishnan
Rankless by CCL
2026